Breaking News Instant updates and real-time market news.

GILD

Gilead

$65.41

0.14 (0.21%)

07:04
04/16/19
04/16
07:04
04/16/19
07:04

Gilead, insitro announce strategic collaboration to develop therapies for NASH

Gilead Sciences and insitro announced that the companies have entered into a strategic collaboration to discover and develop therapies for patients with nonalcoholic steatohepatitis. Under the terms of the three-year collaboration, insitro's proprietary platform will be utilized to create disease models for NASH and discover targets that have an influence on clinical progression and regression of the disease. The insitro Human platform applies machine learning, human genetics and functional genomics to generate and optimize unique in vitro models and drive therapeutic discovery and development. The ISH platform will provide insights into disease progression, suggest candidate targets, and predict patient responses to potential therapeutic interventions. Gilead can advance up to five targets identified through this collaboration and will be responsible for chemistry and development against these targets. Under the terms of the agreement, insitro will receive an upfront payment of $15M, with additional near-term payments up to $35M based on operational milestones. insitro will be eligible to receive up to $200M for the achievement of preclinical, development, regulatory and commercial milestones for each of the five Gilead targets; and up to low double-digit tiered royalties on net sales. For programs where insitro opts in, it will have the right to co-develop and co-detail in the U.S., receive a profit share in China and receive milestone payments and royalties on other ex-U.S. sales.

  • 02

    May

  • 06

    May

  • 08

    May

  • 18

    May

GILD Gilead
$65.41

0.14 (0.21%)

03/15/19
03/15/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Simmons First National (SFNC) initiated with a Buy at DA Davidson. 2. Amgen (AMGN) and Gilead (GILD) initiated with an Outperform at BMO Capital. 3. Rocket Pharmaceuticals (RCKT) initiated with a Buy at BofA/Merrill. 4. Urovant Sciences (UROV) initiated with a Buy at SunTrust. 5. Spectrum (SPPI) assumed with a Buy at Jefferies. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/17/19
PIPR
03/17/19
NO CHANGE
Target $75
PIPR
Neutral
Gilead HIV drugs' price increase 30% lower than prior years, says Piper Jaffray
Piper Jaffray analyst Tyler Van Buren notes that as expected, effective March 16th, Gilead raised list prices of the company's top 6 selling HIV antiviral drugs by 4.9% which includes Atripla, Biktarvy, Descovy, Genvoya, Odefsey, and Truvada. Notably, the price increases were roughly 30% lower than what has been observed in prior years and likely reflects the recent increasing pressure on drug pricing, he contends. The analyst also notes that these increases are well below the high single digit year over year price increases that have been observed with other companies, which Gilead can afford due to strong volume growth of its next generation TAF-based regimens. Van Buren reiterates a Neutral rating and $75 price target on the shares.
04/10/19
UBSW
04/10/19
UPGRADE
Target $77
UBSW
Buy
Gilead upgraded to Buy from Neutral at UBS
UBS analyst Carter Gould upgraded Gilead Sciences to Buy from Neutral and raised his price target for the shares to $77 from $75. Following the failure of selonsertib in nonalcoholic steatohepatitis, Gilead announced "two important clinical wins" in the positive Descovy PrEP data and filgotinib Finch1/3 data, Gould tells investors in a research note. These unlock two $2B-plus revenue opportunities and go "far to de-risk" the company's growth in 2021 and beyond, contends the analyst. Further, while the analyst expects a Q1 earnings miss, he believes 2019 estimates will move higher as NASH precommercialization spend likely comes out of guidance.
04/12/19
RBCM
04/12/19
NO CHANGE
RBCM
Outperform
Intercept's OCA risk-benefit profile still looks solid, says RBC Capital
RBC Capital analyst Brian Abrahams kept his Outperform rating on Intercept (ICPT) after its Regenerate data in the 25mg obeticholic acid, or OCA, study and the subsequent 13% decline in its stock price. The analyst believes that the sell-off was in part a "sell the news" event and also may have been driven by the separately announced 20% sales force layoff at Gilead (GILD), which had been viewed as a potential buyer of NASH assets. Abrahams maintains his view on OCA's benefit/risk profile as "solid", adding that while fundamental concerns around the launch and necessary capital are likely to remain, he expects its "likely approval and broad long-term market opportunity" to become "better appreciated in the medium-term."

TODAY'S FREE FLY STORIES

EPE

EP Energy

$0.16

(0.00%)

15:57
05/23/19
05/23
15:57
05/23/19
15:57
Hot Stocks
Breaking Hot Stocks news story on EP Energy 

EP Energy trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$79.19

1.69 (2.18%)

, WPP

WPP

$59.87

-1.62 (-2.63%)

15:55
05/23/19
05/23
15:55
05/23/19
15:55
Periodicals
Target in talks to buy retail ad firm from WPP, WSJ reports »

Target (TGT) is in talks…

TGT

Target

$79.19

1.69 (2.18%)

WPP

WPP

$59.87

-1.62 (-2.63%)

WMT

Walmart

$101.64

-0.4 (-0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

  • 05

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 18

    Jun

  • 15

    Aug

  • 13

    Nov

PAGS

PagSeguro Digital

$30.89

-0.36 (-1.15%)

15:50
05/23/19
05/23
15:50
05/23/19
15:50
Options
PagSeguro call buyer lays out $1.3M for January upside »

PagSeguro call buyer lays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIR

Circor

$42.63

1.24 (3.00%)

, CR

Crane

$80.47

-1.63 (-1.99%)

15:43
05/23/19
05/23
15:43
05/23/19
15:43
Periodicals
Circor said to cancel from Keybanc conference, Bloomberg reports »

On May 21, Circor…

CIR

Circor

$42.63

1.24 (3.00%)

CR

Crane

$80.47

-1.63 (-1.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAC

AAC Holdings

$1.11

-0.04 (-3.48%)

15:41
05/23/19
05/23
15:41
05/23/19
15:41
Hot Stocks
Addiction Labs of America developing cannabis, CBD pharmacogenetics test »

Addiction Labs of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

MOS

Mosaic

$21.67

-0.67 (-3.00%)

15:40
05/23/19
05/23
15:40
05/23/19
15:40
Options
Bullish risk reversal in Mosaic Company with shares near 18 month lows »

Bullish risk reversal in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Nov

MDR

McDermott

$6.19

-0.64 (-9.38%)

15:34
05/23/19
05/23
15:34
05/23/19
15:34
Hot Stocks
McDermott reaffirms schedule for Freeport LNG project »

McDermott reaffirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

INTU

Intuit

$241.15

-6.37 (-2.57%)

15:34
05/23/19
05/23
15:34
05/23/19
15:34
Options
Intuit options imply 5.3% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AMZN

Amazon.com

$1,811.20

-46.54 (-2.51%)

, GOOG

Alphabet

$1,134.97

-15.53 (-1.35%)

15:31
05/23/19
05/23
15:31
05/23/19
15:31
Periodicals
Amazon-backed self-driving unicorn Aurora buys lidar maker, Forbes says »

According to Alan Ohnsman…

AMZN

Amazon.com

$1,811.20

-46.54 (-2.51%)

GOOG

Alphabet

$1,134.97

-15.53 (-1.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

  • 19

    Jun

  • 25

    Jun

  • 27

    Oct

WPG

Washington Prime

$4.48

0.02 (0.45%)

15:20
05/23/19
05/23
15:20
05/23/19
15:20
Options
Notable put buy in Washington Prime »

Notable put buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

SPLK

Splunk

$128.52

-7.28 (-5.36%)

15:19
05/23/19
05/23
15:19
05/23/19
15:19
Options
Splunk options imply 9.0% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 13

    Jun

  • 09

    Jul

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

15:17
05/23/19
05/23
15:17
05/23/19
15:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOS

Canada Goose

$47.50

-1.605 (-3.27%)

15:16
05/23/19
05/23
15:16
05/23/19
15:16
Periodicals
Breaking Periodicals news story on Canada Goose »

Hedgeye adds Canada Goose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

$NYE

NYSE Market Internals

$0.00

(0.00%)

15:16
05/23/19
05/23
15:16
05/23/19
15:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DTE

DTE Energy

$128.90

0.6 (0.47%)

15:14
05/23/19
05/23
15:14
05/23/19
15:14
Hot Stocks
DTE Energy officer Mark Stiers sells almost $1.3M in company shares »

DTE Energy officer Mark…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

  • 12

    Jun

DNR

Denbury Resources

$1.57

-0.15 (-8.72%)

15:10
05/23/19
05/23
15:10
05/23/19
15:10
Options
Denbury Resources draws call buying as shares probe 2019 lows »

Denbury Resources draws…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

15:10
05/23/19
05/23
15:10
05/23/19
15:10
General news
Treasury Market Summary »

Treasury Market Summary:…

WETF

WisdomTree

$6.13

-0.305 (-4.74%)

15:06
05/23/19
05/23
15:06
05/23/19
15:06
Hot Stocks
WisdomTree CEO Jonathan Steinberg buys over $496K in shares »

WisdomTree CEO Jonathan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

HPQ

HP Inc.

$19.16

-0.13 (-0.67%)

15:04
05/23/19
05/23
15:04
05/23/19
15:04
Options
HP Inc. options imply 7.1% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

TMUS

T-Mobile

$75.93

-0.42 (-0.55%)

, S

Sprint

$6.91

0.22 (3.29%)

15:02
05/23/19
05/23
15:02
05/23/19
15:02
Hot Stocks
Pennsylvania PUC approves application related to proposed Sprint/T-Mobile merger »

The Pennsylvania Public…

TMUS

T-Mobile

$75.93

-0.42 (-0.55%)

S

Sprint

$6.91

0.22 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

MAXR

Maxar Technologies

$7.93

0.78 (10.91%)

14:59
05/23/19
05/23
14:59
05/23/19
14:59
Hot Stocks
Breaking Hot Stocks news story on Maxar Technologies »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMG

Chipotle

$666.60

-39.45 (-5.59%)

14:55
05/23/19
05/23
14:55
05/23/19
14:55
Hot Stocks
Chipotle disagrees with downgrade, sees no major impact from African swine fever »

After BMO Capital analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

MAXR

Maxar Technologies

$7.93

0.78 (10.91%)

14:55
05/23/19
05/23
14:55
05/23/19
14:55
Hot Stocks
Maxar selected to build, fly first element of NASA's Lunar Gateway »

Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$43.33

-1.03 (-2.32%)

14:55
05/23/19
05/23
14:55
05/23/19
14:55
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRNT

Verint

$54.60

-6.61 (-10.80%)

14:54
05/23/19
05/23
14:54
05/23/19
14:54
Recommendations
Verint analyst commentary  »

Oppenheimer says buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.